ABCA7 and Alzheimer disease: Based on the previous reports and the arbitrary positioning of AD associated PTC mutations across the gene (Fig. 1), haploinsufficiency—a reduction of dosage sensitive functional ABCA7—is the most plausible pathogenic mechanism [11, 16, 47].